Publications by authors named "Massimo Fasano"

Claim this Profile
T
Team-based, hybrid, or standard of care? Organizational models of tuberculosis care on tuberculosis outcomes in eleven Italian hospital.
Giacomo Guido, Francesco Di Gennaro, Francesco Cavallin, Mariantonietta Pisaturo, Lorenzo Onorato, Massimo Fasano

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic (STB) and Asymptomatic (ATB) tuberculosis in Italy: Results from a multicenter retrospective study.
Sergio Cotugno, Giacomo Guido, Francesco Di Gennaro, Francesco Cavallin, Mariantonietta Pisaturo, Massimo Fasano

J Clin Tuberc Other Mycobact Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Team-based, hybrid, or standard of care? Organizational models of tuberculosis care on tuberculosis outcomes in eleven Italian hospital" [Clin Microbiol Infect (2025) 31(12) 2033-2040].
Giacomo Guido, Francesco Di Gennaro, Francesco Cavallin, Mariantonietta Pisaturo, Lorenzo Onorato, Massimo Fasano

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematochemical hallmarks as markers of pulmonary TB severity: A multicenter cross-sectional study.
Francesco Di Gennaro, Giacomo Guido, Sergio Cotugno, Francesco Cavallin, Mariantonietta Pisaturo, Massimo Fasano

J Clin Tuberc Other Mycobact Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in tuberculosis diagnostic delays between native and migrant populations in Italy: A multicenter study.
Francesco Di Gennaro, Sergio Cotugno, Giacomo Guido, Francesco Cavallin, Mariantonietta Pisaturo, Massimo Fasano

Int J Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Hepatitis C: Current Status and Future Perspectives.
Massimo Fasano, Francesco Ieva, Marianna Ciarallo, Bruno Caccianotti, Teresa Antonia Santantonio

Viruses· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic prophylaxis in invasive urodynamics, a Delphi consensus of the Italian Society of Urodynamics (SIUD).
Emanuele Rubilotta, Elisabetta F Chiarulli, Enrico Ammirati, Marianna C Bevacqua, Stefano Manodoro, Massimo Fasano

Neurourol Urodyn· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia.
Massimo Fasano, Michele Milella, Sergio Carbonara, Paolo Tundo, Salvatore Minniti

Front Public Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High risk of unsuccessful treatment outcome in migrant population with tuberculosis: Data from three Italian hospitals.
Francesco Di Gennaro, Sergio Cotugno, Massimo Fasano, Aurelia Ricciardi, Luigi Ronga

Front Public Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation as Prognostic Hallmark of Clinical Outcome in Patients with SARS-CoV-2 Infection.
Diana Fuzio, Angelo Michele Inchingolo, Vitalba Ruggieri, Massimo Fasano, Maria Federico

Life (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Chronic Hepatitis B in HIV-Coinfected Patients.
Massimo Fasano, Maria Cristina Poliseno, Josè Ramon Fiore, Sergio Lo Caputo, Antonella D'Arminio Monforte

Viruses· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.
Giuseppina Brancaccio, Massimo Fasano, Adriano Grossi, Teresa Antonia Santantonio, Giovanni B Gaeta

Aliment Pharmacol Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The present profile of chronic hepatitis B virus infection highlights future challenges: An analysis of the Multicenter Italian MASTER-B cohort.
Giuseppina Brancaccio, Alessandra Nardi, Salvatore Madonia, Massimo Fasano, Gabriella Verucchi

Dig Liver Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.
Mauro Viganò, Alessandro Loglio, Sara Labanca, Serena Zaltron, Francesco Castelli, Massimo Fasano

Liver Int· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Data From the Study of Coagulative Profile of HIV Infected Individuals Suggest a Role For Point Mutations in the Gene in Protein S Deficiency in Individuals Undergoing Highly Antiretroviral Therapy.
Mariantonietta Di Stefano, Giovanna D'Andrea, Fabio Zoboli, Giuseppina Faleo, Massimo Fasano

Open AIDS J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.
Mikael Gencay, Kirsten Hübner, Peter Gohl, Anja Seffner, Michael Weizenegger, Massimo Fasano

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between knowledge on transmission and prevention of HIV/STI and proficiency in condom use among male migrants from Africa and Middle East evaluated by a Condom Use Skills score using a wooden penile model.
Fabio Zoboli, Domenico Martinelli, Mariantonietta Di Stefano, Massimo Fasano, Rosa Prato

BMC Res Notes· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients.
Massimo Fasano, Paolo Maggi, Armando Leone, Anna Volpe, Jose Ramon Fiore

Dig Liver Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study.
Giuseppe Bruno, Annalisa Saracino, Claudia Fabrizio, Luigia Scudeller, Eugenio Milano, Massimo Fasano

Int J Antimicrob Agents· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flares during long-term entecavir therapy in chronic hepatitis B.
Heng Chi, Pauline Arends, Jurriën G P Reijnders, Ivana Carey, Ashley Brown, Massimo Fasano

J Gastroenterol Hepatol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
José R Fiore, Fabio Zoboli, Mariantonietta Di Stefano, Giuseppina Faleo, Massimo Fasano

AIDS· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians.
Pauline Arends, Milan J Sonneveld, Roeland Zoutendijk, Ivana Carey, Ashley Brown, Massimo Fasano

Gut· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study.
Paolo Maggi, Vincenzo Montinaro, Armando Leone, Massimo Fasano, Anna Volpe

J Antimicrob Chemother· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR.
Giuseppe Bruno, Massimo Fasano, Annalisa Saracino, Anna Volpe, Nicola Bartolomeo

New Microbiol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance.
Orazio Palmieri, Antonio M Ippolito, Maurizio Margaglione, Maria R Valvano, Domenica Gioffreda, Massimo Fasano

Liver Int· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis